Thomas Wüest

824 total citations
14 papers, 690 citations indexed

About

Thomas Wüest is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas Wüest has authored 14 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas Wüest's work include Peptidase Inhibition and Analysis (8 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Polyamine Metabolism and Applications (2 papers). Thomas Wüest is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Polyamine Metabolism and Applications (2 papers). Thomas Wüest collaborates with scholars based in Germany, Switzerland and United States. Thomas Wüest's co-authors include Dieter Moosmayer, Klaus Pfizenmaier, Michael A. Kertesz, Elke Gerlach, Arthur A. Hurwitz, Jami Willette‐Brown, Scott K. Durum, Nathalie Peters, Peter Scheurich and Harald Wajant and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Thomas Wüest

13 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Wüest Germany 12 309 265 230 115 99 14 690
Zewei Wang China 17 310 1.0× 314 1.2× 252 1.1× 110 1.0× 49 0.5× 62 836
Shigeki Tashiro Japan 12 414 1.3× 132 0.5× 58 0.3× 89 0.8× 31 0.3× 44 778
Shiri Klein Israel 21 584 1.9× 245 0.9× 206 0.9× 126 1.1× 27 0.3× 38 1.2k
Xin Wei China 17 317 1.0× 130 0.5× 215 0.9× 106 0.9× 34 0.3× 36 730
Gabriele Varano Italy 11 377 1.2× 137 0.5× 261 1.1× 161 1.4× 14 0.1× 15 791
J. Zha United States 6 321 1.0× 198 0.7× 257 1.1× 83 0.7× 24 0.2× 11 662
Kikyung Jung South Korea 11 363 1.2× 263 1.0× 109 0.5× 369 3.2× 18 0.2× 35 913
Hiroko Fukami Japan 16 305 1.0× 126 0.5× 89 0.4× 102 0.9× 28 0.3× 42 749
Laura San‐Segundo Spain 18 599 1.9× 344 1.3× 130 0.6× 113 1.0× 21 0.2× 44 1.0k
Meta W. Djojosubroto Germany 7 402 1.3× 123 0.5× 72 0.3× 58 0.5× 21 0.2× 8 680

Countries citing papers authored by Thomas Wüest

Since Specialization
Citations

This map shows the geographic impact of Thomas Wüest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wüest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wüest more than expected).

Fields of papers citing papers by Thomas Wüest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wüest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wüest. The network helps show where Thomas Wüest may publish in the future.

Co-authorship network of co-authors of Thomas Wüest

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wüest. A scholar is included among the top collaborators of Thomas Wüest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wüest. Thomas Wüest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fischer, Eliane, Thomas Wüest, Andreas Wadle, et al.. (2012). Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies. Clinical Cancer Research. 18(22). 6208–6218. 79 indexed citations
2.
Thiel, Markus, Hiroyoshi Nishikawa, Thomas Wüest, et al.. (2010). Tumor-specific Crosslinking of GITR as Costimulation for Immunotherapy. Journal of Immunotherapy. 33(9). 925–934. 16 indexed citations
3.
Ospelt, Caroline, Joachim C. Mertens, Astrid Jüngel, et al.. (2010). Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis & Rheumatism. 62(5). 1224–1235. 58 indexed citations
4.
Wüest, Thomas, et al.. (2010). Antibody targeting of epithelial carcinoma-associated fibroblast activation protein blocks cellular proliferation, migration, and invasion.. Journal of Clinical Oncology. 28(15_suppl). e13062–e13062.
5.
Bauer, Stefan, Jeannette Oosterwijk‐Wakka, Nicole Adrian, et al.. (2009). Targeted therapy of renal cell carcinoma: Synergistic activity of cG250‐TNF and IFNg. International Journal of Cancer. 125(1). 115–123. 34 indexed citations
6.
Bauer, Stefan, Nicole Adrian, Natalie Fadle, et al.. (2009). Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8. PubMed. 9. 2–2. 10 indexed citations
7.
Wüest, Thomas, Jami Willette‐Brown, Scott K. Durum, & Arthur A. Hurwitz. (2008). The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. Journal of Leukocyte Biology. 84(4). 973–980. 82 indexed citations
8.
Wüest, Thomas, Gerald W. Both, Alfred M. Prince, Christian Hofmann, & Peter Löser. (2004). Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice. Vaccine. 22(21-22). 2717–2721. 29 indexed citations
9.
Wüest, Thomas, et al.. (2002). TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor. Oncogene. 21(27). 4257–4265. 28 indexed citations
10.
Wajant, Harald, Dieter Moosmayer, Thomas Wüest, et al.. (2001). Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Oncogene. 20(30). 4101–4106. 174 indexed citations
11.
Wüest, Thomas, Dieter Moosmayer, & Klaus Pfizenmaier. (2001). Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein. Journal of Biotechnology. 92(2). 159–168. 32 indexed citations
12.
Schmidt, Alexej, Dafne Müller, Thomas Wüest, et al.. (2001). Generation of human high‐affinity antibodies specific for the fibroblast activation protein by guided selection. European Journal of Biochemistry. 268(6). 1730–1738. 30 indexed citations
13.
Wietek, Claudia, et al.. (1999). Genetic organization of sulphur‐controlled aryl desulphonation in Pseudomonas putida S‐313. Molecular Microbiology. 32(5). 913–926. 47 indexed citations
14.
Kertesz, Michael A., et al.. (1999). A Novel Reduced Flavin Mononucleotide-Dependent Methanesulfonate Sulfonatase Encoded by the Sulfur-RegulatedmsuOperon ofPseudomonas aeruginosa. Journal of Bacteriology. 181(5). 1464–1473. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026